Literature DB >> 11485681

Measles outbreak in a community with very low vaccine coverage, the Netherlands.

S van den Hof1, C M Meffre, M A Conyn-van Spaendonck, F Woonink, H E de Melker, R S van Binnendijk.   

Abstract

A 1999-2000 measles epidemic in the Netherlands started with an outbreak in an orthodox reformed elementary school with 7% vaccine coverage. The overall attack rate was 37%: 213 clinical cases among the 255 participating pupils (response 62%) and 327 household members. The attack rate ranged from 0% for the oldest groups of pupils to 88% for the youngest, who had not been exposed in previous measles epidemics. None of 25 vaccinated pupils had clinical symptoms. Among pupils with clinical symptoms, the self-reported complication rate was 25%. These data confirm that measles infection causes severe disease and that vaccination is the most effective means of preventing the disease and its complications. The data also show that clusters of persons refraining from vaccination interfere with measles elimination even in populations with very high overall vaccine coverage (96%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485681      PMCID: PMC2631830          DOI: 10.3201/eid0707.010743

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  8 in total

1.  [Measles epidemiology in the Netherlands: a exploratory analysis of notification].

Authors:  J Wallinga; S van den Hof
Journal:  Ned Tijdschr Geneeskd       Date:  2000-01-22

2.  Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors.

Authors:  S Huiss; B Damien; F Schneider; C P Muller
Journal:  Clin Exp Immunol       Date:  1997-09       Impact factor: 4.330

3.  Measles outbreak in a fully immunized secondary-school population.

Authors:  T L Gustafson; A W Lievens; P A Brunell; R G Moellenberg; C M Buttery; L M Sehulster
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

4.  [The immunization status of patients registered with measles during the 1987-88 epidemic].

Authors:  H Bijkerk; M A Bilkert-Mooiman; H J Houtters
Journal:  Ned Tijdschr Geneeskd       Date:  1989-01-07

5.  Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

Authors:  S van den Hof; G A Berbers; H E de Melker; M A Conyn-van Spaendonck
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

6.  Genotyping of measles virus isolates from central Europe and Russia.

Authors:  S Santibanez; A Heider; E Gerike; A Agafonov; E Schreier
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

7.  Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.

Authors:  E Vardas; S Kreis
Journal:  J Clin Virol       Date:  1999-08       Impact factor: 3.168

8.  Nonclassic measles infections in an immune population exposed to measles during a college bus trip.

Authors:  R F Helfand; D K Kim; H E Gary; G L Edwards; G P Bisson; M J Papania; J L Heath; D L Schaff; W J Bellini; S C Redd; L J Anderson
Journal:  J Med Virol       Date:  1998-12       Impact factor: 2.327

  8 in total
  19 in total

1.  Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

Authors:  Gaby P Smits; Pieter G van Gageldonk; Leo M Schouls; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

2.  Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem.

Authors:  C Stein-Zamir; G Zentner; N Abramson; H Shoob; Y Aboudy; L Shulman; E Mendelson
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

3.  Polio and Measles Down the Drain: Environmental Enterovirus Surveillance in the Netherlands, 2005 to 2015.

Authors:  Kimberley S M Benschop; Harrie G van der Avoort; Edin Jusic; Harry Vennema; Rob van Binnendijk; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

4.  Retrospective identification of three undiagnosed cases of measles encephalitis.

Authors:  Y A Nur; J Groen; A Abdallah; H Kruining; R L De Swart; A D M E Osterhaus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 5.103

5.  Description of two measles outbreaks in the Lazio Region, Italy (2006-2007). Importance of pockets of low vaccine coverage in sustaining the infection.

Authors:  Filippo Curtale; Fabrizio Perrelli; Jessica Mantovani; Marta Ciofi degli Atti; Antonietta Filia; Loredana Nicoletti; Fabio Magurano; Piero Borgia; Domenico Di Lallo
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

6.  Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires.

Authors:  Liesbeth Mollema; Nancy Wijers; Susan J M Hahné; Fiona R M van der Klis; Hendriek C Boshuizen; Hester E de Melker
Journal:  BMC Public Health       Date:  2012-01-20       Impact factor: 3.295

7.  Measles outbreak, the Netherlands, 2008.

Authors:  Susan Hahne; Margreet J M te Wierik; Liesbeth Mollema; Eva van Velzen; Eric de Coster; Corien Swaan; Hester de Melker; Robert van Binnendijk
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

8.  A measles epidemic threshold in a highly vaccinated population.

Authors:  Jacco Wallinga; Janneke C M Heijne; Mirjam Kretzschmar
Journal:  PLoS Med       Date:  2005-10-18       Impact factor: 11.069

9.  Complex social contagion makes networks more vulnerable to disease outbreaks.

Authors:  Ellsworth Campbell; Marcel Salathé
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Parents' perceived vulnerability and perceived control in preventing Meningococcal C infection: a large-scale interview study about vaccination.

Authors:  Danielle R M Timmermans; Lidewij Henneman; Remy A Hirasing; Gerrit van der Wal
Journal:  BMC Public Health       Date:  2008-02-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.